Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma

ClinicalTrials.gov ID: NCT01239797

Public ClinicalTrials.gov record NCT01239797. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 2:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (MM)

Study identification

NCT ID
NCT01239797
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
646 participants

Conditions and interventions

Interventions

  • Dexamethasone Drug
  • Dexamethasone (IV) Drug
  • Dexamethasone (Oral) Drug
  • Elotuzumab (BMS-901608; HuLuc63) Biological
  • Lenalidomide Drug

Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 19, 2011
Primary completion
Sep 1, 2014
Completion
Apr 20, 2021
Last update posted
May 31, 2022

2011 – 2021

United States locations

U.S. sites
63
U.S. states
25
U.S. cities
56
Facility City State ZIP Site status
Northwest Alabama Cancer Center, Pc Muscle Shoals Alabama 35661
Acrc/Arizona Clinical Research Center, Inc. Tucson Arizona 85715
Local Institution Berkeley California 94704
Local Institution Burbank California 91505
Compassionate Cancer Res Grp Corona California 92879
Local Institution Corona California 92879
San Diego Pacific Oncology& Hematology Associates, Inc Encinitas California 92024
Local Institution Greenbrae California 94904
Ucla-Division Of Hematology/Oncology Los Angeles California 90095
Medical Oncology Care Associates Orange California 92868
Sharp Clinical Oncology Research San Diego California 92123
Local Institution Vallejo California 94589
Local Institution Boca Raton Florida 33486
Cancer Care Centers Of Florida Brooksville Florida 34613
Mount Sinai Comprehensive Cancer Center Miami Beach Florida 33140
Local Institution New Port Richey Florida 34652
Cancer Institute Of Florida Orlando Florida 32804
Local Institution Titusville Florida 32796
Florida Cancer Specialists West Palm Beach Florida 33401
Winship Cancer Institute. Atlanta Georgia 30322
Georgia Health Science University Augusta Georgia 30912
Orchard Healthcare Research Inc. Skokie Illinois 60077
Local Institution Indianapolis Indiana 46260
Local Institution Mishawaka Indiana 46545
Local Institution Iowa City Iowa 52242
Local Institution Lexington Kentucky 40503
Local Institution Louisville Kentucky 40207
Pikeville Medical Center Pikeville Kentucky 41501
Cancer Center Of Acadiana At Lafayette General Lafayette Louisiana 70503
Local Institution Shreveport Louisiana 71101
Local Institution Shreveport Louisiana 71103
Willis Knighton Cancer Center Shreveport Louisiana 71103
Dana Farber Cancer Inst Boston Massachusetts 02215
Dana-Farber Cancer Institute Boston Massachusetts 02215
Henry Ford Health System Detroit Michigan 48202
Capitol Comprehensive Cancer Care Center Jefferson City Missouri 65101
Local Institution Springfield Missouri 65807
Washington University School Of Medicine St Louis Missouri 63110
Local Institution Las Vegas Nevada 89106
NYU Clinical Cancer Center New York New York 10016
Local Institution New York New York 10019
Weill Cornell Medical College New York New York 10065
Local Institution Stony Brook New York 11794-8151
Levine Cancer Institute Charlotte North Carolina 28204
Gaston Hematology & Oncology Gastonia North Carolina 28054
Local Institution Bismarck North Dakota 58501
University Of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Local Institution Tulsa Oklahoma 74136
Local Institution Bethlehem Pennsylvania 18015
Western Pennsylvania Hospital Pittsburgh Pennsylvania 15224
Local Institution Charleston South Carolina 29414
Local Institution Greenville South Carolina 29615
Local Institution Knoxville Tennessee 37909
The West Clinic Memphis Tennessee 38120
Cancer Specialists Of South Texas, Pa Corpus Christi Texas 78412
Ut Southwestern Medical Center Dallas Texas 75390-8565
University Of Texas Md Anderson Cancer Ctr Houston Texas 77030
Northwest Cancer Center Houston Texas 77090
Hematology-Oncology Associates Of Fredricksburg, Inc Fredericksburg Virginia 22408
Va Puget Sound Health Care System Seattle Washington 98108
Gundersen Clinic, Ltd La Crosse Wisconsin 54601
University Of Wisconsin Hospital And Clinics Madison Wisconsin 53792
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 153 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01239797, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 31, 2022 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01239797 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →